Esperion Therapeutics, Inc.

ESPRNasdaq· Pharmaceutical Preparations

Price History

Revenue

$403.1M

▲ 21.3% YoY

Net Income

-$22.7M

▲ 56.2% YoY

EPS

$-0.11

▲ 60.7% YoY

Cash

$167.9M

▲ 16.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.